Hellerup, Denmark

Günter Ditzinger

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Union Therapeutics A/s. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Günter Ditzinger. Retrieved from https://idiyas.com/inventor/günter-ditzinger-r428b0i5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Günter Ditzinger

Introduction

Günter Ditzinger is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating viral infections. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

Ditzinger's latest patents focus on niclosamide formulations for treating diseases associated with SARS-CoV-2. The inventions detail a method of treating viral infections by administering a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin. This innovative approach aims to provide an effective treatment option for those affected by the virus.

Career Highlights

Throughout his career, Ditzinger has been associated with Union Therapeutics A/S, where he has played a crucial role in advancing pharmaceutical research. His expertise in drug formulation has positioned him as a key figure in the fight against viral infections.

Collaborations

Ditzinger has collaborated with notable colleagues, including Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.

Conclusion

Günter Ditzinger's contributions to the field of pharmaceuticals, particularly through his recent patents, highlight his commitment to addressing critical health challenges. His work continues to inspire advancements in treatment methodologies for viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…